Art – Precision BioPharma

PB-004

Precision BioPharma is an innovative company with an Adaptive Translational Research approach and AI-driven research process. Our compound, PB-004, has a huge potential to save lives of COVID-19 patients through…

PB-200

PB-200 is planned for Phase 2B trials to alleviate COVID-19 induced pneumonia. PB-200 is an FDA approved drug which is being repurposed by Precisin BioPhama for COVID-19, alone and in…

Rich pre-clinical pipeline

Precision BioPharma has a rich pre-clinical product pipeline consisting of anti viral, anti-inflammatory and anti thrombotic molecules.

Portfolio Category: Art